2012-04-30
Eight annual PEGS
April 30 – May 4, 2012, Boston, USA
On Friday May 5, Dr. Fredrik Frejd, VP Research, will present in the session "Antibodies and beyond: The future of the field."
The title of the presentation is "Engineered high-affinity affibody Molecules targeting Platelet-Derived Growth Factor receptor β in Vivo".